Overall opioid cost and utilization continue to drop, due in part to market, societal, and regulatory influences, and the trend is expected to continue. To hear more about how providers and patients are looking to opioid alternatives for pain management, view the latest video blog.
More stories
WorkcompWire
In the News
Enlyte Releases 2025 Drug Trends Report, Part 1: Opioids Down, Migraine Meds Up
Workers' Comp
Article
Ask The Pharmacist: Bird Flu and Its Growing Impact on Public Health
How serious is the threat of bird flu in North America? Bird flu, or avian influenza, is an emerging public health and industry conce
Business Insurance
In the News
Migraine meds on rise in comp despite overall drop in scripts
Business Hangout
In the News
Drug Use Insights: Migraines Rise While Opioids Decline
Claims Journal
In the News
Enlyte: Migraine Medications Continue Rising in Workers’ Comp
Workers' Comp
News Release
Enlyte Drug Trend Report: Migraine Med Use Soars in Comp Despite Overall Drop in Scripts
Annual PBM report shows increases in overall migraine meds use by nearly 9%, while opioids drop by almost 8%SAN DIEGO – April 30,